MAIA Biotechnology
MAIA
MAIA
6 hedge funds and large institutions have $1.04M invested in MAIA Biotechnology in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
60% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 5
Holders
6
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$176K | |
| 2 | +$141K | |
| 3 | +$1.06K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$7 |
Top Sellers
| 1 | -$39K | |
| 2 | -$34K | |
| 3 | -$5.47K | |
| 4 |
OIA
Optimum Investment Advisors
Chicago,
Illinois
|
-$3K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1K |